Salmeterol Xinafoate

規格

94749-08-3CAS番号

638-765-3EC番号

2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol;1-hydroxynaphthalene-2-carboxylic acidIUPAC名

C36H45NO7化学式

603.7 g/mol分子量

salmeterol xinafoate; 94749-08-3; Serevent diskus; Salmeterol 1-hydroxy-2-naphthoate; GR 33343 G; DTXSID1045798; 6EW8Q962A5; GR-33343 G; DTXCID9025798; ADVAIR COMPONENT SALMETEROL XINAFOATE; AIRDUO RESPICLICK COMPONENT SALMETEROL XINAFOATE; Xinafoate, Salmeterol; RefChem:56524; Serevent; 4-(1-Hydroxy-2-((6-(4-phenylbutoxy)hexyl)amino)ethyl)-2-(hydroxymethyl)phenol 1-hydroxy-2-naphthoate; 2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol;1-hydroxynaphthalene-2-carboxylic acid; MFCD00897708; Salmeterol (xinafoate); NCGC00094372-03; Asmerole; Betamican; Dilamax; Inaspir; Ultrabeta; Serevent Inhaler and Disks; Salmeterol xinafoate [USAN]; SMR000875207; CAS-94749-08-3; UNII-6EW8Q962A5; Salmetedur;; Betamican;; Aeromax;; Inaspir;; Beglan;; C36H45NO7; Arial;; Salmeterol xinafoate [USAN:USP]; Serevent (TN); 4-[1-Hydroxy-2-[[6-(4-phenylbutoxy)hexyl]amino]ethyl]-2-(hydroxymethyl)phenol 1-Hydroxy-2-naphthoate; Salmeterol Xinafoate; (1RS)-1-[4-Hydroxy-3-(Hydroxymethyl)phenyl]-2-[[6-(4-phenylbutoxy)hexyl]amino]ethanol 1-hydroxynaphthalene-2-carboxylate; GR 33343G; GR 33343G; Salmeterol xinafoate?; Salmeterol xinafoate CRS; SCHEMBL18070; (+-)-4-Hydroxy-alpha(sup 1)-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-m-xylene-alpha,alpha'-diol 1-hydroxy-2-naphthoate (salt); MLS001332577; MLS001332578; orb315513; CHEBI:9012; LIPO-202; orb1223547; orb1300582; SCHEMBL2833182; CHEMBL1082607; SCHEMBL29352164; SCHEMBL29372524; Salmeterol xinafoate (JAN/USP); HMS2232I16; HMS3263K22; HMS3676P13; HMS3749I03; HMS3885J19; HMS5083C07; Salmeterol (xinafoate) (Standard); SALMETEROL XINAFOATE [JAN]; Salmeterol 1-hydr oxy-2-naphthoate; SALMETEROL XINAFOATE [VANDF]; Tox21_111270; Tox21_501100; EBC-97122; HY-17453R; MSK000735; s4296; SALMETEROL XINAFOATE [MART.]; SALMETEROL XINAFOATE [USP-RS]; SALMETEROL XINAFOATE [WHO-DD]; AKOS016004957; Tox21_111270_1; CCG-270203; CS-1527; FS27784; KS-1140; LP01100; MSK000735-100M; NCGC00015938-05; NCGC00094372-01; NCGC00094372-02; NCGC00094372-04; NCGC00261785-01; (+/-) 4-Hydroxy-a1-[[[6-(4-phenylbutoxy)hexyl]amino]m-ethyl]-1,3-benzenedimethanol xinafoate; 1,3-Benzenedimethanol, 4-hydroxy-alpha(sup 1)-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-, (+-)-, 1-hydroxy-2-naphthalenecarboxylate (salt); HY-17453; SALMETEROL XINAFOATE [EP IMPURITY]; SALMETEROL XINAFOATE [ORANGE BOOK]; SY047289; SALMETEROL XINAFOATE [EP MONOGRAPH]; DB-057527; SALMETEROL XINAFOATE [USP MONOGRAPH]; A3190; EU-0101100; NS00076193; T6653; Salmeterol xinafoate, >=98% (HPLC), solid; D00687; LIPO-102 COMPONENT SALMETEROL XINAFOATE; R10007; SALMETEROL 1-HYDROXY-2-NAPHTHOATE [MI]; Salmeterol xinafoate for system suitability CRS; ADVAIR HFA COMPONENT SALMETEROL XINAFOATE; Salmeterol xinafoate for peak identification CRS; F858001; SR-01000597359; SR-01000597359-1; Q27264747; Salmeterol Xinafoate Solution in Methanol, 100ug/mL; Salmeterol xinafoate, European Pharmacopoeia (EP) Reference Standard; Salmeterol xinafoate, United States Pharmacopeia (USP) Reference Standard; Salmeterol xinafoate for system suitability, European Pharmacopoeia (EP) Reference Standard; Salmeterol Xinafoate, Pharmaceutical Secondary Standards; Certified Reference Material; (+/-)-4-HYDROXY-.ALPHA.(SUP 1)-(((6-(4-PHENYLBUTOXY)HEXYL)AMINO)METHYL)-M-XYLENE-.ALPHA.,.ALPHA.'-DIOL 1-HYDROXY-2-NAPHTHOATE; 1,3-BENZENEDIMETHANOL, 4-HYDROXY-.ALPHA.(SUP 1)-(((6-(4-PHENYLBUTOXY)HEXYL)AMINO)METHYL)-, (+/-)-, 1-HYDROXY-2-NAPHTHALENECARBOXYLATE; 1-Hydroxynaphthalene-2-carboxylic acid--2-(hydroxymethyl)-4-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)phenol (1/1); 2-Naphthalenecarboxylic acid, 1-hydroxy-, compd. with 4-hydroxy-alpha1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol (1:1); 4-[1-Hydroxy-2-[[6-(4-phenylbutoxy)hexyl]amino]ethyl]-2-(hydroxymethyl)phenol compd. with 1-Hydroxy-2-naphthoic Acid (1:1); 4-Hydroxy-?1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol 1-hydroxy-2-naphthalenecarboxylic acid; Salmeterol Xinafoate Micronized別名